CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Resident Rights
(Tag F0550)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations and interviews conducted during the Recertification survey from 01/19/2023 to 01/26/2023, the facility did...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations and interviews conducted during the Recertification survey from 01/19/2023 to 01/26/2023, the facility did not ensure each resident was treated with respect and dignity and cared for in a manner that promoted maintenance or enhancement of their quality of life. Specifically, the facility did not ensure the resident was appropriately dressed to maintain privacy and was not exposed to passersby in the hallway when wearing a hospital gown. This was evident for 1 of 2 residents reviewed for Dignity out of a sample of 38 residents. (Resident # 351)
The findings are:
The facility policy and procedure titled Respect and Dignity dated 7/95 with a revision date of 8/2022 documented that all residents will be treated with respect and dignity, ensuring the residents has their correct clothing, neat and well groomed.
Resident #351 was admitted to the facility with the diagnoses of Unspecified Depression, Muscle Weakness, Syncope and Collapse, Benign Prostatic Hyperplasia, Retention of Urine.
The Minimum Data Set (MDS) dated [DATE] documented that the resident had moderately impaired cognitive status. The MDS also documented the resident required extensive assistance with one-person physical assist on toilet use, and extensive assistance with 2-person physical assist for bed mobility and dressing.
During an observation on 01/19/2023 at 10:46 AM and at 3:50 PM, Resident #351 was observed in bed, with no clothing on the upper part of the body and wearing an incontinence brief only. Resident was visible to passersby from the hallway.
On 1/20/2023 at 9:52 AM, accompanied by the Registered Nurse Supervisor (RNS) #2, Surveyor observed Resident # 351 lying in bed wearing a hospital gown drawn up to their shoulder exposing the chest and abdominal area. Resident #351 was also wearing only an incontinence brief and the privacy curtain was open so Resident #351 was visible to passersby in the hallway. RNS #2 immediately pulled the hospital gown to cover resident's upper body and called the staff to care for Resident #351.
During an interview on 1/26/2023 at 11:46 AM Certified Nursing Assistant (CNA) #5 stated Resident #351 verbalized to them that they feel hot and so raises their clothing up. CNA #5 also stated that resident has their own clothes and they did not know where the hospital gown came from.
ON 1/26/2023 at 11:48 AM, RNS# 2 was interviewed and stated not properly dressing resident is not acceptable, they should be dressed appropriately, and an in-service will be given to staff to promote and maintain resident's dignity.
During an interview on 1/26/2023 at 2:07 PM, the Director of Nursing (DON) stated they are aware that Resident #351's privacy was not maintained and staff were in serviced that respect and dignity must be observed at all times.
415.5(a)
CONCERN
(D)
📢 Someone Reported This
A family member, employee, or ombudsman was alarmed enough to file a formal complaint
Potential for Harm - no one hurt, but risky conditions existed
Notification of Changes
(Tag F0580)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview conducted during the Recertification and Complaint Survey (NY00295200) from 1/19/23 t...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview conducted during the Recertification and Complaint Survey (NY00295200) from 1/19/23 to 1/26/23, the facility did not ensure that the resident and the resident representative was promptly notified when there was a need to alter treatment significantly (that is, a need to adjust an existing medication, and to commence a new form of treatment). Specifically, the facility did not notify the resident's representative when Resident's medication was increased. This was evident for 1 of 1 resident reviewed for Notification of Change out of a sample of 38 residents (Resident #61).
The findings are:
The facility Policy titled Change in Resident dated 02/2017, last revised 06/2022 documented that family members will be advised if there is a change in resident condition- this includes clinical changes, medication changes, weight changes etc.
Resident #61 was admitted to the facility with diagnoses that included Seizure Disorder, Non-Alzheimer's Dementia, and Hemiplegia or Hemiparesis.
The Quarterly Minimum Data Set (MDS) dated [DATE] documented the resident had severe impairment in cognition with long and short-term memory problems and required total dependence of staff for most activities of daily living.
Intake Information received for Complaint #NY00295200 dated 5/2/22, documented that the complainant reported that Resident #61 has been over medicated without consulting the power of attorney. The Complainant reported that the facility did not call or notify the family of the increase nor the reason for the increase of the dosage. The Complainant also stated that Divalproex 250 mg was ordered to be given 3 times daily when the resident was in the hospital and the facility decided to increase it to 500 mg every 12 hours without consulting with the family.
The Physician's order dated 07/21/2021 documented: Depakote 250 mg tab PO 3 times per day for Gen idiopathic epilepsy; Citalopram 10 mg PO daily for Major depressive disorder.
The Medication Administration Record (MAR) dated from 07/21/2021 to 02/20/2022 documented that resident was administered Depakote 250 mg tab PO 3 times per day.
The Physician's order dated 02/21/2022 documented Divalproex Sodium 500mg tab PO every 12 hours, (Discontinued 4/22/2022).
Medication Administration Record (MAR) dated from 02/21/2022 to 04/22/2022 documented that resident was administered Depakote 500 mg PO every 12 hours.
The Physician's Order dated 11/03/2022: Valproic Acid (As Sodium Salt) (Valproic Acid) 250 MG/5ML, Give 250 mg (5 mL) per tube Every 12 Hours.
On 01/19/23 at 11:24 AM, the Complainant was interviewed and stated that Resident #61 was admitted to the facility and prescribed Divalproex sodium 250 mg 1 tablet 3 times per day and this was increased to 500mg every 12 hours by the facility without notifying the family members of the increase and the reason for the change of the medication. The Complainant further stated that the medication increase reacted on the resident which led to the resident's hospitalization.
Progress note Medical dated 2/24/2022 documented 2/16/22 Psych consult - continue with Celexa 20 mg daily, change Depakote from 250 mg PO TID to 500mg Q12 hrs. VPA (Valproic Acid Level) 53.4, therapeutic.
There was no documented evidence that family was notified when the medication was increased.
The Progress Note Nursing dated 2/23/2022 14:25 documented that Resident remain calm with no behavior display, last Psych consult done 2/14/22. Divalproex increased from 250mg to 500mg.
There was no documented evidence that the family was informed about the increase in medication dosage.
The Progress Note Nursing dated 2/23/2022 22:36 documented that Resident remained calm with no behavior displayed, in bed visiting with their child. Divalproex increase from 250mg to 500mg.
There was no documented evidence that the family was notified of the change in dosage.
On 01/24/23 at 12:44 PM, an interview was conducted with the Registered Nurse (RN) #1. RN #1 stated that Resident #61 has been on Depakote 250mg via GT every 12 hours for Seizure activities since they have been providing care for the resident. RN #1 also stated that whenever there is a change in resident's medication or resident's condition, the family member is notified to get the approval, if the family is not in agreement, the doctor will be informed to speak with the family. RN #1 stated that she/he did not know that Resident #61's family was not made aware when the medication was changed.
On 01/24/23 at 12:11 PM, an interview was conducted with the Registered Nurse Supervisor, (RNS) #1. RNS #1 stated that resident's family was supposed to have been notified when the medication was changed but they did not know why this was not done. RNS #1 stated that resident was on another unit when the medication was changed. RNS further stated that a note from the Psych dated 2/16/2022 documented recommendation to increase the Depakote from 250mg and MD note of 2/21/2022 documented that resident's medication was changed from 250mg TID to 500mg Q12H, but there was no note that documented that the family had been notified. RNS #1 further stated that the nurse that picks up the recommendation of the Psych is supposed to notify the family, and the resident if alert, to see if they agree with recommendation, and then notify the physician to get the order.
On 01/24/23 at 02:03 PM, an interview was conducted with the Psychiatric Medical Doctor (PMD). The PMD stated that Resident #61's Depakote was recommended to be increased in February 2022 because of resident's increased aggressive behavior to staff during care. The PMD also stated that the family was expected to be notified by the nursing or by the ordering physician when the recommendation was approved and ordered.
On 01/24/23 at 02:18 PM, an interview was conducted with the Medical Doctor (MD) #1. MD #1 stated that Resident's medication was increased based on the recommendation from the Psychiatrist and they could not remember or recall speaking with the resident's family member then, as it had been almost a year now. MD #1 also stated that the Psychiatrist could have informed the family when the recommendation was made.
On 01/26/23 at 09:55 AM, an interview was conducted with the Director of Nursing (DON). The DON stated that the family is supposed to be notified by the physician or the nurse if there is a change in the resident's medication. The DON also stated that they were not aware of the problem, but whoever initiated the change in the medication should have notified the family member.
415.3(f)(2)(ii)(c)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Incontinence Care
(Tag F0690)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review conducted during a Recertification survey from 01/19/2023 to 01/26/2023, the f...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review conducted during a Recertification survey from 01/19/2023 to 01/26/2023, the facility did not ensure that residents received appropriate care and treatment to prevent potential urinary tract infections. Specifically, 1). There was no physician order for care and treatment of the Nephrostomy tube (a Nephrostomy tube is a thin plastic tube that is passed from the back, through the skin and then through the kidney, to the point where the urine collects), and 2). Proper infection control measures were not maintained to prevent the potential development and transmission of infections for a resident with a urinary catheter connected to a drainage bag which was not properly monitored. This was evident for 2 of 4 residents reviewed for Urinary Catheter or UTI out of a sample of 38 residents. (Resident # 5 and #351)
The finding is:
1. The facility policy titled Reconciliation of Physician Orders revised 7/2022 documented; it is the policy of this organization that based on hospital paperwork, consultant recommendation orders will be entered into Wellsky if attending physician is in agreement and to ensure that there are no discrepancies.
The facility policy titled Foley Catheter/Suprapubic Catheter Drainage/Nephrostomy Tube: Insertion and Care created 6/2014 and revised 7/2021 documented that the nurse should check the physician order for purpose of catheterization, type, and size of catheter.
Resident #5 was readmitted to the facility on [DATE] with diagnoses which included Acute Kidney Failure, local infection of the skin, Type 2 Diabetes Mellitus, and Cerebral palsy.
On 1/23/2023 at 11 AM, Resident #5 was observed with a drainage bag that was attached to the catheter connected to the resident's back area on the right side.
Review of the hospital Patient Review Instrument (PRI) dated 1/3/2023 documented Resident with nephrostomy tube and treated with 7-day course of Bactrim for possible pyelonephritis, to continue care and treatment of nephrostomy tube.
Review of physician Order Summary Report dated 1/3/2023 revealed no documentation of any orders related to care and treatment of the Nephrostomy tube.
Physician notes dated 1/4/2023 documented Resident #5 was recently admitted to the hospital for UTI (Urinary Tract Infection) associated with nephrostomy catheter-resolved as of 1/1/ 2023.
The Comprehensive Care Plan (CCP) dated 1/4/2023 documented Resident #5 has nephrostomy tube. The CCP documented a goal that the resident will be free from infection.
Review of the Physician Progress Notes dated 1/11/2023 revealed there was no documentation that Resident #5 had a nephrostomy tube in place.
There was no documented evidence that Nephrostomy care had been provided.
During an interview on 1/26/2023 at 9:49 AM, Certified Nursing Assistant (CNA) #4 stated Resident #5 has a drainage bag that has urine in it and resident does not complain of any discomfort.
During an interview on 1/25/2023 at 11:43 AM, the Medical Director stated there should be an order for nephrostomy tube, care, and treatment. The Medical Director also stated this was missed upon admission and the primary doctors must review orders from hospital upon the resident's admission to the facility.
During an interview on 1/25/2023 at 12:34 PM, the Director of Nursing (DON) stated an order should have been written upon admission and it was an oversight. The DON further stated an in-service will be conducted to ensure staff properly document residents who have a nephrostomy tube, and the care and treatment that is to be given.
2. The facility policy and procedure titled Foley Catheter Care dated 6/2014 revised 07/2021, documented keep drainage bag below level of the bladder and off the floor.
Resident #351 was admitted to the facility with diagnoses that included Benign Prostatic Hyperplasia, Retention of urine, Essential Hypertension and Muscle Weakness.
The Minimum Data Set (MDS) dated [DATE] documented that the resident had moderately impaired cognitive status. The MDS also documented the resident required extensive assistance with one person physical assist for toilet use and that the resident has an indwelling catheter.
The Comprehensive Care Plan dated 1/1/2023 for indwelling catheter documented goal was that the resident will be free of infection and interventions were to ensure tubing is free of kinks, below level of bladder and drainage bag off the floor.
The Physician's Order dated 01/11/2023 documented Foley Care every shift.
On 01/19/2023 at 10:46 AM and 01/20/2023 at 9:23 AM, Resident #351 was observed in bed with the lower half of the foley drainage bag containing approximately 200 ccs of yellow colored urine laying on the floor.
On 01/20/2023 at 2:20 PM, during an observation with Registered Nurse (RN) #2, the foley drainage bag was observed laying on the floor. RN #2 immediately took the drainage bag off the floor and attached it to the lower side of bed so it no longer touched the floor.
On 01/26/2023 at 11:46 AM, an interview was conducted with Certified Nursing Assistant (CNA) #5. CNA#5 stated the resident needs extensive assistance for care and there are times the foley drainage bag is observed on the floor and they put it up so as not to touch the floor. CNA #5 also stated the hook of the drainage bag might have been dislodged and that is why the bag was on the floor sometimes.
On 01/26/2023 at 2 :30 PM, an interview was conducted with the unit Registered Nurse (RN) #2. RN #2 stated that the staff were in-serviced that the foley drainage bag must always be off the floor. RN #2 further stated that the foley drainage bag was repositioned when it was found on the floor in the presence of the surveyor.
On 01/26/2023 at 3:07 PM, an interview was conducted with the Infection Control Preventionist (ICP) who is also the Director of Nursing (DON). The ICP/DON stated that the nurses on the units, the supervisors are responsible for ensuring that staff are observing infection control practices when giving care to the residents. The ICP/DON also stated that the problem was brought to their attention today, and they will ensure that the resident and staff are re-educated on proper infection prevention protocols.
415.12(d)(1)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Drug Regimen Review
(Tag F0756)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interviews conducted during the Recertification survey from 1/19/23 to 1/26/23, the facility di...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interviews conducted during the Recertification survey from 1/19/23 to 1/26/23, the facility did not ensure that irregularities identified by the pharmacist and forwarded to the facility were acted upon. Specifically, the facility failed to document in the resident's medical record that irregularities identified by the Consultant Pharmacist had been reviewed and what, if any, action had been taken to address the irregularities. This was evident for 1 of 5 residents reviewed for Unnecessary Medications out of a sample of 38 residents. (Resident # 88)
The finding is:
The Long Term Solutions Pharmaceutical Consultant Policy and procedure for Drug Regimen Review provided by the facility on 01/26/2023 documented: .Drug regimen reviews (DRR) that require physician intervention will be responded to by the physician/designee within 7 days. The attending physician/designee completes the DRR and accepts or rejects the consultant pharmacist recommendations. If the recommendation is declined, the physician/designee provides a rational for refusal of the recommendation in the medical record.
Resident #88 was admitted to the facility with diagnoses that included Non-Alzheimer's Dementia, Anxiety disorder, Depression, Psychotic Disorder.
The Annual Minimum Data Set (MDS) dated [DATE] documented the resident had severe impairment in cognition. The MDS also documented Antipsychotic and Antidepressant were administered on a routine basis only; gradual dose reduction (GDR) has not been attempted, and GDR has not been documented by a physician as clinically contraindicated.
Psychiatry note dated 8/30/22 documented that Resident #88 had no behavioral issues and denied confusion and psychotic symptoms. The note also documented that resident was not as animated as usual and reported low mood. Psychiatrist's recommendation included increase Lexapro to 10mg daily for depressed mood and continue Risperdal 1mg in AM and 2mg at bedtime.
On 09/12/2022, the Medication Regimen Review (MRR) documented: Please note: The resident was seen by Psych on 8/30/22 and recommendations are noted. Please address.
Physician's order dated 10/12/2022 documented: Risperidone (Risperdal) 2 mg by mouth twice daily.
Escitalopram Oxalate (Escitalopram Oxalate) 5 mg, by mouth daily.
Physician/Prescriber Response dated 10/31/2022, over 48 days later, documented Agree.
There was no documented evidence that resident's medication had been adjusted nor was there documentation as to why action was not going to be taken.
On 01/10/2023, the MRR documented: Please consider trial GDR (Gradual Dose Reduction) Risperdal in lethargic resident on Palliative care. No noted behaviors.
There was no documented evidence that a follow up Psych consult had been ordered for possible review or consideration of trial GDR as recommended on the MRR.
On 01/25/23 at 11:21 AM, an interview was conducted with the Registered Nurse Supervisor (RNS) #1. RNS #1 stated that they just returned to work and was not aware that a GDR was not done for the resident's psychotropic medication. RNS #1 also stated that from review of the resident's chart, Resident #88 had not been displaying any behavior problem recently and had not been re-assessed by the Psych MD for over 3 months. RNS #1 further stated that pharmacy recommendations regarding MRR are usually sent to the Director of Nursing (DON) and MD to address. RNS #1 stated that they were not aware that pharmacy recommendations had not been addressed until now.
On 01/26/23 at 09:21 AM, an interview was conducted with the MDS Coordinator (MDSC). The MDSC stated that Resident #88's psychotropic medication was expected to be tapered, and if not, there should be documentation why the GDR was not done. The MDSC was unable to explain why MRR recommendation was not acted upon by the physician.
On 01/26/23 at 09:41 AM, an interview was conducted with the Director of Nursing (DON). The DON stated that the Consulting Pharmacist reviews the resident's medication regimen every month, and their recommendation is documented in the resident's medical record. The DON also stated that an email is sent to the Director of Nursing and the Medical Director that there are recommendations in the resident's chart to be reviewed. The medical team reviews the recommendations to make sure the recommendations are addressed. The DON further stated that they do not know and cannot explain why the GDR was not done for Resident #88.
On 01/26/23 at 11:16 AM, an interview was conducted with the Attending Physician (MD #2). MD #2 stated that the Pharmacist recommendation is received from the computer, and action is taken within 3 days. Most of the time the recommendation is reviewed the next day, but sometimes when they are at the meeting when the recommendation is received, it can be missed. MD #2 also stated that when a Psych consult is recommended, it is usually ordered immediately, and the psych consult is usually done within 2 weeks. MD #2 further stated that the Pharmacy recommendation for the resident psych consult was missed because the resident was re-admitted .
415.18 (c)(2)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0757
(Tag F0757)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview conducted during the Recertification survey from 1/19/23 to 1/26/23, the facility did...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview conducted during the Recertification survey from 1/19/23 to 1/26/23, the facility did not ensure that the residents drug regimens were free from unnecessary drugs. Specifically, the facility did not document the diagnosed condition for which a medication is prescribed. This was evident for 1 of 5 residents reviewed for Unnecessary Medication out of a sample of 38 residents (Resident #20).
The findings are:
A facility policy titled Admission/readmission Monthly Physician Orders, revised September 2022, states That all orders will be reviewed monthly and approved by the physician. The purpose is to ensure proper documentation of resident's orders.
Resident #20 was admitted to the facility with diagnoses that included Hypertension, Non-Alzheimer's Dementia, and Depression.
The admission Minimum Data Set 3.0 (MDS) dated [DATE] documented that Resident #20 had severely impaired cognition, and trouble concentrating and moving/speaking slowly 12-14 days and there were no behaviors exhibited.
The Physician's orders dated 10/14/22 documented Aricept 10 mg at bedtime order for encounter for general adult medical examination with abnormal findings and Namenda 10 mg twice daily for encounter for general adult medical examination with abnormal findings.
The Pharmacist Medication Regiment Review dated 10/14/22 and 12/20/22 did not reflect any recommendations for the need for appropriate diagnosis for either of these medications.
The facility did not document the diagnosed condition for which a medication was prescribed.
During an interview conducted on 1/25/23 at 10:15 AM, Registered Nurse (RN) #2 stated that the doctor gives the diagnosis for the medication and a nurse cannot just enter a diagnosis.
During an interview conducted on 1/25/23 at 11:00 AM, the Assistant Director of Nursing Services (ADNS) stated the hospital discharge paperwork is reviewed and a diagnosis is attached to the prescribed medications. The ADNS also stated that the RN admitting the resident can match the medication to the diagnosis list that is included in the discharge paperwork and they will also call the physician for the diagnosis. The ADNS further stated that the monthly orders are reviewed by the Pharmacist to ensure that the medication diagnosis is correct. The ADNS reviewed the electronic medical record and stated that the diagnosis entered for Aricept and Namenda was not appropriate.
During an interview conducted via telephone, on 1/25/23 at 10:54 AM, the Medical Doctor (MD) #1 stated that when they see the resident, they review medication and blood results. MD #1 also stated that they check the dosage of medication and they usually do not check the diagnosis. The Supervisor puts the diagnosis in on admission. MD #1 further stated that the Well Sky (electronic medical records program) is a problem as they enter the ICD 10 codes and sometimes the diagnosis does not come up the right. The Pharmacy will call, and I will correct the diagnosis. MD#1 reviewed the diagnosis attached to Namenda and stated it was not an appropriate diagnosis.
415.12(l)(1)
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0657
(Tag F0657)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 3. Resident #140 had diagnoses which included Parkinson's disease, Cerebrovascular disease, and Type 2 Diabetes Mellitus.
The Q...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 3. Resident #140 had diagnoses which included Parkinson's disease, Cerebrovascular disease, and Type 2 Diabetes Mellitus.
The Quarterly Minimum Data Set (MDS) assessment dated [DATE] documented that Resident #140 was cognitively intact with a Brief Interview for Mental Status (BIMS) score of 15/15. Section Q of the MDS also documented that the resident had participated in the assessment, and family or significant other had not participated in the assessment.
On 1/20/2023 at 10:23 AM, Resident #140 was interviewed and stated that they were only invited to 1 care planning meeting in the last 3 years.
A Social Service Care Conference note dated 3/30/2022 documented a care plan meeting was held today with Resident #140 via teleconference.
A document titled Weekly Care Plan Meeting dated 3/30/2022 documented Resident #140 attended their annual care plan meeting.
There was no documented evidence in the medical records that Resident #140 was invited to participate in the review and revision of comprehensive care plans or attended quarterly care plan meetings.
On 1/25/2023 at 4:08 PM, Social Worker (SW) #1 was interviewed and stated residents and their representatives are invited to initial, annual, and Significant Change care plan meetings, and are not invited to participate in quarterly meetings.
On 1/26/2023 at 11:22 AM, the SW Director (SWD) was interviewed and stated the last time Resident #140 was invited to a care plan meeting was the Annual which was held on 3/30/2022. The SWD also stated that residents are invited to the initial, annual, and significant change care plan meetings. The SWD further stated we do not invite to residents to quarterly meetings unless the resident or their representative requests a meeting.
On 01/26/23 at 10:02 AM, an interview was conducted with the Director of Nursing (DON). The DON stated that Social Services (SS) in coordination with the MDS generates the list of residents due for care plan meeting. The DON also stated that the SS team notifies the resident/family and should document it in the residents' medical records. The DON further stated that residents are only invited to the initial, significant change and annual meetings and they are not invited to attend quarterly meetings.
415.11(c)(2)(i-iii)
Based on record review, and staff interviews conducted during the Recertification survey conducted from 1/19/2023 to 1/26/2023, the facility did not ensure that Resident or Resident's representative were offered the opportunity to participate in the revision and/or review of the comprehensive care plan. Specifically, resident and resident's representatives were not consistently invited to participate in their care plan meetings. This was evident for 3 of 3 residents reviewed for Care Planning out of 38 residents sampled (Residents #159, #160 and #140).
The findings are:
The facility Policy on Comprehensive Care Plan (CCP) dated 09/2007, last revised 06/2022 documented the Resident is afforded the right to participate in the care planning or was consulted about care and treatment changes .Social Service Secretary sends letter of invite to the designated Resident representative .uploads copy of invite into the document tab in the residents' EMR; Maintains CCP log of contact information dates, times, etc. and maintains in Social Service office for 1 year .
1. Resident #159 was admitted to the facility with diagnoses that included Coronary Artery Disease (CAD), Cerebrovascular Accident (CVA), Hemiplegia, Asthma, Chronic Obstructive Pulmonary Disease (COPD).
The Quarterly Minimum Data Set (MDS) dated [DATE] documented that the resident had intact cognitive status with a Brief Interview for Mental Status (BIMS) score of 14/15 and required extensive assistance or was totally dependent on staff for most activities of daily living. Section Q of the MDS also documented that the resident and family or significant other participated in the assessment.
The MDS Assessments dated 12/11/21, 3/7/22, 4/20/22 and 7/21/22 also documented that resident had intact cognition with a BIMS score of 14 or 15.
On 01/19/23 at 10:48 AM, Resident #159 was observed in their room during the initial pool process and interviewed. Resident #159 stated that they sometimes hear the announcement over the air that a meeting is going on, but they have never been invited to any of the meetings and was not aware that any of the family members has been invited.
There was no documented evidence that the resident or family had been invited to or participated in any of the care plan meetings since admission.
Social Services progress note dated 01/18/2023 at 11:13 AM documented that a care plan meeting was held with Resident #159's family members via conference call with the clinical team present.
There was no documented evidence that Resident #159 was notified of the quarterly meetings or given the opportunity to participate in the review and revision of comprehensive care plans despite having intact cognitive status.
Progress note Dietary dated 01/18/2023 12:30 PM documented that care plan meeting held with Resident's family members via phone. Primary nutrition source is enteral feeding/H20 flushes. Pleasure feedings provided with minimal intake. Family requesting swallowing re-evaluation to encourage increased PO intake. SLP notified.
There was no documented evidence that Resident #159 was notified of the meeting or given an opportunity to discuss their choice of feeding.
Progress Note Nursing dated 01/19/2023 08:34 AM documented that IDT care plan meeting conducted with team and family member. Resident was receiving Atorvastatin. Reconciled with MD, resident no longer requires Atorvastatin. Cholesterol is controlled. Atorvastatin Discontinued.
There was no documented evidence that Resident #159 was given an opportunity to discuss about the medication being administered despite being cognitively intact.
2. Resident #160 was admitted to the facility with diagnoses that included Hypertension, Diabetes Mellitus, and Non-Alzheimer's Dementia.
The Quarterly Minimum Data Set (MDS) dated [DATE] documented the resident had severe impairment in cognition and required extensive assistance/total dependence of staff for most activities of daily living. MDS section Q0100 documented that resident and resident's family or significant other participated in the assessment.
On 01/19/23 at 12:01 PM, Resident #160's family member was interviewed and stated that they were last invited for and participated in the resident's CCP meeting almost a year ago.
There was no documented evidence that Resident #160's family member was afforded the opportunity to participate in the review and revision of comprehensive care plans or attended quarterly care plan meetings.
On 01/24/23 at 12:51 PM, an interview was conducted with the Registered Nurse (RN) #1. RN #1 stated that the interdisciplinary team members will inform the resident and the family members of the meeting prior the meeting, and document on the resident's chart if resident/family member were invited and attended the meeting.
On 01/25/23 at 10:34 AM, an interview was conducted with the Assistant Director of Nursing (ADON) who stated that the list of residents scheduled for care plan meeting is prepared by the MDS staff. The list is given to the Social Worker to notify the resident, if a resident is alert and oriented, and to the family member if resident is not alert and oriented. This is supposed to be documented in the resident's medical record by the Social Services. The ADON also stated that they were not aware that Resident #160 was not being invited to participate in CCP meetings.
On 01/25/23 at 11:22 AM, an interview was conducted with Social Worker (SW) #1. SW #1 stated that they call the family and speak with the residents that are cognitively intact, and sometimes they take the residents to their care plan meeting, unless the resident declines or if the family say they want to represent the resident. SW #1 also stated that Resident #159 was asked some time ago to attend the meeting, but will always ask the family to attend on their behalf. SW #1 further stated that they cannot remember if it was documented that Resident #159 preferred the family to represent them at the CCP meeting.
There was no documented evidence that Resident #159 had been invited to and declined to attend any meeting.
On 01/26/23 at 09:07 AM, an interview was conducted with the MDS Coordinator (MDSC). The MDSC stated the MDS staff will set up the schedule of CCP meetings for the residents which is then given to Interdisciplinary Team (IDT) members. The IDT clerk will notify the family and document it in the logbook and the Social Worker will notify the cognitively intact residents verbally and document it, and they will document the attendance after the meeting. The MDSC further stated that the resident and the family members are invited for the comprehensive CCP meetings such as the initial, annual, and significant change, and they were not sure if the resident and the family members are being invited to quarterly CCP meetings.
CONCERN
(E)
📢 Someone Reported This
A family member, employee, or ombudsman was alarmed enough to file a formal complaint
Potential for Harm - no one hurt, but risky conditions existed
Medication Errors
(Tag F0758)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. Resident #107 was admitted to the facility on [DATE] with diagnoses that included Anxiety Disorder, muscle weakness, Unspecif...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. Resident #107 was admitted to the facility on [DATE] with diagnoses that included Anxiety Disorder, muscle weakness, Unspecified Dementia, history of falling.
Complaint intake for NY00307787 dated 12/30/22 documented a family member reported that Resident #107 had multiple falls and had a language barrier as they spoke Spanish only.
The admission MDS dated [DATE] documented that Resident #107 had a diagnosis of Dementia and Anxiety Disorder and was not prescribed antipsychotic, antianxiety or antidepressant medication during the last 7 days or since admission or re-entry. The MDS also documented that resident's preferred language was Spanish and resident needed an interpreter to communicate with a doctor or healthcare staff.
The Minimum Data Set (MDS) assessment dated [DATE], documented the resident had moderately impaired cognition, did not have any behaviors for that time period, and had diagnoses that included Dementia, Anxiety disorder and Depression. The MDS also documented that the resident received Antipsychotic medication on 4 of 7 days and Antidepressant medication on 3 of 7 days during the assessment period.
On 01/20/23 at 11:27 AM, Resident #107 was observed seated in the common area in their wheelchair. Resident was calm, no signs of distress noted.
On 1/23/2023 at 10:30 AM, Resident #107 was observed in bed, and stated they were doing fine and had no complaint. Resident was calm with no signs of agitated or aggressive behavior observed.
On 1/24/2023 at 11:30 AM, Resident #107 was observed in the dining room and stated they were waiting for lunch. Resident was calm and was able to answer simple questions and displayed no aggressive or agitated behavior.
The [NAME] (used by Certified Nursing Assistants {CNA} to guide daily care) dated 6/23/2022 to 01/25/2023 did not include documentation regarding any behaviors or resident specific interventions if behaviors were displayed.
The Occurrence Report dated 7/29/2022, documented resident was observed on the floor of the bathroom with no injury noted. Preventative measures included resident needs for toiletings were anticipated and encouraged to use call bell.
The Occurrence Report dated 8/16/2022 documented resident was found sitting on the floor near bed at 1:10 PM, no injury noted. Investigation documented resident was attempting to transfer back to bed from wheelchair and fell to the floor, PT and OT were ordered for evaluation for safe transfers.
The Occurrence Report dated 10/25/2022 documented resident attempted to stand up while sitting in wheelchair and fell to the floor. Bleeding from nose was observed and resident was sent to hospital for evaluation, returned the following day. The Occurrence Report also documented that Lexapro was discontinued at the hospital.
The Occurrence report dated 12/1/2022 documented resident attempted to transfer self from wheelchair to bed and was found on the floor. No injury was noted. Resident continues PT and OT.
Review of Occurrence report dated 12/18/2022 documented resident was found on the floor in their room with skin tear at the back of the head. Resident was sent to the hospital and returned to facility the following day.
There was no documented evidence that Resident #107's medication regimen was reviewed following each fall incident to determine whether use of psychotropic medication use contributed to frequent falls.
The Order list dated 6/23/22 to 10/24/22 provided by the facility contained no documented evidence that Resident #107 was prescribed an antipsychotic medication on admission to the facility.
The Order list documented the following orders and diagnoses:
Quetiapine Fumurate (Seroquel) Give 25mg by mouth at bedtime with a start date of 7/7/22 and an end date of 8/18/22 for Depression unspecified.
Escitalopram Oxalate give 5mg by mouth daily with a start date of 7/8/22 and an end date of 7/26/22 for Depression unspecified.
Quetiapine Fumurate (Seroquel) Give 12.5mg by mouth every morning with a start date of 7/22/22 and an end date of 9/15/22 for Anxiety Disorder Unspecified.
Escitalopram Oxalate give 10mg by mouth daily every morning with a start date of 7/27/22 and an end date of 8/26/22 for Anxiety Disorder unspecified.
Quetiapine Fumurate (Seroquel) Give 25mg by mouth at bedtime with a start date of 8/13/22 and an end date of 9/30/22 for Depression unspecified.
Escitalopram Oxalate give 15mg by mouth daily every morning with a start date of 8/26/22 and an end date of 10/26/22 for Anxiety Disorder unspecified.
Quetiapine Fumurate (Seroquel) Give 25mg by mouth twice daily with a start date of 9/30/22 and an end date of 10/25/22. There was no diagnosis indicated.
Quetiapine Fumurate (Seroquel) Give 12.5mg by mouth daily at 0800 with a start date of 10/1/22 and an end date of 10/26/22. There was no diagnosis indicated.
Quetiapine Fumurate (Seroquel) Give 12.5mg by mouth daily at 0800 with a start date of 10/27/22 and an end date of 12/18/22 for a diagnosis of Schizophrenia unspecified.
Psychiatry note dated 7/13/22 documented resident had diagnoses of anxiety and dementia and was on psych meds. The note also documented that Resident was recently started on Lexapro and Seroquel per out patient provider recommendation and per chart patient has been confused which interferes with treatment. The note also documented that the resident was not able to provide details about history, unable to state how long in nursing home or why there and denied psychiatric symptoms or other concerns. Resident denied depression, confusion, psychotic symptoms, and memory deficits. The note also documented it would be preferable to titrate Lexapro to a therapeutic dose and aim for GDR of Seroquel given risk of cardiovascular events in dementia patients.
Psychiatry note dated 7/26/22 documented resident had diagnoses of anxiety and dementia and was on psych meds. Case was discussed due to persistent agitation including screaming, which is disruptive to other residents, subsequently Seroquel 12.5mg every morning was added. The note also documented that resident is confused, agitated, yelling out, not redirectable and antipsychotic will be used temporarily while titrating the antidepressant medication. Lexapro increased to 10mg.
Psychiatry note dated 8/24/22 documented resident continues to frequently yell out for help, often not verbally redirectable and had a fall on 8/16/22. Plan included increasing Lexapro again for better effect on anxiety, after 2 weeks can begin GDR of Seroquel. Increase Lexapro to 15mg PO daily for Anxiety. After 2 weeks on higher dose of Lexapro discontinue AM dose of Seroquel and continue Seroquel 25mg at bedtime.
Psychiatry note dated 9/14/22 documented per chart no aggression or overt behavioral outburst. The note also documented Lexapro at a therapeutic dose which should allow for GDR of Seroquel. The note also documented consider discontinuing AM dose of Seroquel and continuing Seroquel 25 mg at bedtime to reduce risks of falls and adverse cardiovascular events. If pt having frequent behavioral issues can continue morning dose and will re-assess at next visit.
Psychiatry note dated 9/14/22 documented resident was post antibiotic therapy for Urinary Tract Infection. The note also documented resident was still having behavioral issues despite adequate dosing of Lexapro. The note also documented repeat urinalysis and culture to ensure UTI has fully cleared.
Psychiatry note dated 10/5/22 documented resident is intermittently restless and calls out for help though the resident s more familiar with the people and environment. The psych note also documented resident denied symptoms and was not displaying aggression.
Review of Nursing Progress notes dated 6/23/2022 to 01/19/2023 contained no consistent documentation regarding resident's behavior and non-pharmacological interventions utilized to manage the resident's behaviors prior to the use of psychotropic medication.
There was no documented evidence that Resident #107 displayed psychotic behaviors or that an appropriate diagnosis was documented when an antipsychotic medication was prescribed for a resident with a diagnosis of Dementia.
There was no evidence that a complete psychiatric evaluation utilizing standardized screening tools was conducted prior to entering a diagnosis of Schizophrenia when using an antipsychotic medication for a resident diagnosed with Dementia.
During an interview conducted on 01/26/2023 at 11:38 AM, Certified Nursing Assistant (CNA) #4 stated that Resident #107 had fallen a few times and they always check the resident. CNA #4 also stated Resident #107 sometimes yells but they had not seen any behavior in a while.
During an interview conducted on 01/26/2023 01:48 PM, Registered Nurse (RN) #1 stated Resident #107 displays behaviors at times and nursing should document this in behavioral notes in the medical record. RN #1 also stated that in reviewing the medical record, they were only able to find one note per month where Resident #107's behaviors were documented and the documentation did not include non-pharmacological approaches.
During an interview conducted on 01/26/2023 at 3:16 PM, the Director of Nursing (DON) stated that behavior as exhibited by residents must be documented timely and proper use of psychotropic medications and adherence to state and federal guidelines must be followed.
During an interview conducted on 01/26/2023 at 3:30 PM, Resident #107's Physician who is also the facility Medical Director (MD) stated that they usually have nursing link medication orders to a legitimate diagnosis and that themedical staff should have documented the appropriate diagnosis/condition. The MD also stated that they try to attempt gradual dose reductions and review the resident's behaviors with the nurses and Behavioral Health Team. The MD further stated that they do try to keep medications in their notes updated but sometimes mistakes are made, and they will need to do a better job at documenting behaviors.
415.12(1)(2)(ii)
Based on observation, record reviews, and staff interviews conducted during the Recertification/Complaint Survey (NY00307787), the facility did not ensure that each resident's drug regimen remained free from unnecessary drugs and residents who use psychotropic drugs receive behavioral interventions, unless clinically contraindicated, in an effort to discontinue these drugs. Specifically, 1). A gradual dose reduction was not done for a resident as recommended by the Psychiatrist for a resident without behavioral symptoms, and 2). Antipsychotic medication was used without an appropriate diagnosis and there was no documentation of behaviors or non-phamacological interventions utilized. This was evident for 2 of 5 residents reviewed for Unnecessary Medications out of 38 sampled residents. (Residents #88, and #107)
The findings are:
1. The facility Policy and Procedure for Psychotropic Medication management dated 12/10/2017, last revised 2/22/2018 documented that the facility will ensure that each resident's drug regimen is free from unnecessary psychotropic drugs, and from excessive doses or duration of psychotropic drugs; to ensure that adequate monitoring of psychotropic drugs is in effect and has the proper indication for use; to ensure in the presence of adverse consequences the dose of psychotropic drugs is reduced or discontinued, and to ensure that gradual dose reduction (GDR) is attempted as per regulations unless contraindicated, as determined by the medical provider.
Resident #88 was admitted to the facility on [DATE], with diagnoses that included Non-Alzheimer's Dementia, Anxiety disorder, Depression, Psychotic Disorder.
The Annual Minimum Data Set (MDS) dated [DATE] documented the resident had severe impairment in cognition. The MDS documented Antipsychotic and Antidepressant were administered on a routine basis only; gradual dose reduction (GDR) had not been attempted, and a GDR had not been documented by a physician as clinically contraindicated.
On 01/25/23 at 09:34 AM, Resident #88 was observed for Wound Care done by the unit RN. Resident was alert and verbally responsive and able to answer to Yes or No questions. Resident was calm and cooperative and followed directions during the wound care observation, no behavior problem displayed by the resident.
The Comprehensive Care Plan (CCP) for Psychiatric Drug Use dated 10/23/2022 documented that Resident has potential for adverse effect of Psych meds. Goals included: - Resident will have reduced incidents of mood or behavior change by 4/11/2023 and will demonstrate decreased need for psychoactive medication. Interventions included document resident's behavior pattern; Establish appropriate diagnosis for medication use; Assess need for psychotherapeutic medication; Evaluate for reduction of medication dose; Assess behavior pattern daily; Assess effectiveness of medication.
Psychiatry note dated 6/8/22 documented that resident was seen on 6/6/22 based on a referral after Resident # 88 had multiple falls. Psychiatry recommendation was DECREASE Risperdal 1mg PO (orally) q (every) AM + 2mg PO HS (at bedtime).
Behavior Note dated 7/20/2022 documented that Resident is on Risperidone 2 mg PO BID (twice daily) as per psych visit of 6/8/22 .Resident remains alert, oriented and responsive, no signs of aggressive behavior at this time, very calm and cooperative .
Behavior Notes dated 7/7/2022, 7/20/2022, 9/29/2022, 10/14/2022, 11/10/2022, 12/8/2022, and 1/4/2023 documented that Resident #88 had not displayed behavior that has impact on resident or others.
Psychiatry note dated 8/30/22 documented that Resident #88 had no behavioral issues and denied confusion and psychotic symptoms. The note also documented that resident was not as animated as usual and reported low mood. Psychiatrist's recommendation included increase Lexapro to 10mg daily for depressed mood and continue Risperdal 1mg in AM and 2mg at bedtime.
The Physician's order dated 10/12/2022 documented: Risperidone (Risperdal) 2 mg by mouth twice daily (for Psychotic Disorder). Escitalopram Oxalate (Escitalopram Oxalate) 5 mg, by mouth daily (for Depression).
Review of the Medication Administration record from June 2022 to January 2023 documented that resident continued to receive Risperdal 2mg orally twice daily.
There was no documented evidence that resident exhibited behaviors that supported ongoing use of an antipsychotic medication.
There was no documented evidence that antipsychotic medication was decreased as recommended by the Psychiatrist on 6/8/22 or adjusted as recommended on 8/30/22.
On 01/10/2023, the MRR documented: Please consider trial GDR Risperdal in lethargic resident on Palliative care. No noted behaviors.
There was no documented evidence that any action had been taken on the pharmacist's recommendation regarding a dosage reduction for an antipsychotic medication.
During an interview conducted on 01/24/23 at 11:55 AM, Certified Nursing Assistant (CNA) #1 stated that they have been assigned to the resident on a monthly rotational basis since Resident #88 was admitted to the unit over 2 years ago. CNA #1 also stated that in the past Resident #88 was able to perform most activities of daily living by self, able to wheel self on and off unit downstairs independently, but now resident has declined, and requires extensive assistance for all activities of living. CNA #1 further stated that resident is very calm and has not been noted with any behavior issues during care.
During an interview conducted on 01/24/23 at 12:33 PM, Registered Nurse (RN) #1 stated that Resident #88 is on Citalopram 5 mg PO daily for depression and Risperidone 2mg PO BID for Bipolar disorder. RN #1 also stated that resident used to be aggressive with other residents and would be shouting at other residents when they are talking. RN #1 further stated that Resident #88 is quieter now, and has been observed with significant change in status, declining in most activities of daily living. Staff has been monitoring resident's behavior and has been documenting in the behavioral notes that resident is cooperative and calm with no negative behavior, and no behavioral issues noted during care. RN #1 was unable to explain why the Resident #88 had not been re-evaluated by the Psychiatrist for possible GDR since MRR's recommendation.
During an interview conducted on 01/25/23 at 11:21 AM, Registered Nurse Supervisor (RNS) #1 stated that they just returned to work and was not aware that a GDR had not been conducted for Resident #88. RNS #1 reviewed the resident's chart and stated that Resident #88 had not been displaying any behavior problem recently, and had not been re-assessed by the Psych MD for over 3 months.
During an interview conducted on 01/26/23 at 09:21 AM, the MDS Coordinator (MDSC) stated that resident's psychotropic meds is expected to be reduced and if not, there should be documentation as to why the GDR was not done. The MDSC also stated that during the MDS assessment, the Assessor goes by what is documented in the resident's chart and they noted that no GDR was done, and that there was no reason documented why the GDR had not been done. The MDSC further stated they were unable to explain why the pharmacy recommendations were not acted upon by the physician.
During an interview conducted on 01/26/23 at 09:41 AM, the Director of Nursing (DON) stated that the Consulting Pharmacist reviews the resident's medication regimen every month, and their recommendation is documented in the resident's medical record. The medical team reviews the recommendations to make sure the recommendations are addressed. The DON further stated that they do not know and cannot explain why the GDR was not done for the resident.
During an interview conducted on 01/26/23 at 11:16 AM, the Attending Physician (MD #2) stated the Pharmacist recommendation is received from the computer, and action is taken within 3 days, most of the time the recommendation is reviewed the next day, but sometimes when they are at the meeting when the message is received, it can be missed. MD also stated that when the Psych consult is recommended, it is usually ordered immediately, and the psych consult is usually done within 2 weeks. MD #2 further stated that the Pharmacy recommendation for the resident psych consult was missed, and in error the Psychiatric consult had not been ordered for possible GDR since the resident was re-admitted .
MINOR
(B)
Minor Issue - procedural, no safety impact
MDS Data Transmission
(Tag F0640)
Minor procedural issue · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview conducted during the Recertification survey conducted from [DATE] to [DATE], the faci...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview conducted during the Recertification survey conducted from [DATE] to [DATE], the facility did not ensure that within 7 days after a facility completes a resident's assessment, they encoded and transmitted a subset of data upon a resident's transfer, reentry, discharge, and death. This was evident for 3 of 5 residents reviewed for Resident Assessment out of a sample of 39 residents. Specifically, there was no evidence that a Discharge Minimum Data Set (MDS) was submitted for Residents #80 and #179, and that a Death in Facility MDS was submitted for Resident #68.
The findings are:
The Archcare and Affiliated Entities policy, titled PDPM, MDS Completion, last revision/review date of [DATE], documented that the MDS is completed on all residents according to a mandated assessment schedule, ensure all MDS assessments are completed timely and transmitted to CMS. The policy also documented that the MDS Coordinator's responsibility is to complete a schedule for MDS assessment reference date and completion, ensure all assessments are submitted to CMS within 14 days of MDS completion and check the QIES system for the CASPER reports to ensure that all assessments have been submitted timely.
1. Resident #80 was admitted to the facility on [DATE].
A Nursing Progress Note dated [DATE] documented that Resident #80 was discharged to the community.
There was no documented evidence that a Discharge MDS had been submitted following the resident's discharge.
2. Resident #179 was admitted to the facility on [DATE].
A Nursing Progress note dated [DATE] documented that Resident #179 was discharged to another nursing home.
There was no documented evidence that a Discharge MDS had been submitted following the resident's discharge.
3. Resident #68 was admitted to the facility on [DATE].
A Medical Progress note dated [DATE] documented that resident expired in the facility on that date.
There was no documented evidence that a Death in the Facility MDS had been submitted following the resident's death.
On [DATE] at 03:13 PM, an interview was conducted with the MDS Director (MDSD) who stated that there are two full time and two per diem assessors who are assigned to different units. The MDSD also stated the WellSky (electronic medical record program) triggers for missing assessments and they get a report at the end of the day which indicates which MDS assessments have been completed. The MDSD also stated that late reports should be flagged in the system and will alert if an assessment is missing. The MDSD further stated that all assessors can complete discharge MDS assessments and they did not know how these MDS assessments had been missed.